Clinical TrialParallelKetaminePlaceboTerminated

The Effect of Brief Potent Glutamatergic Modulation on Cocaine Dependence

This project will evaluate the effect of a single sub-anesthetic dose of ketamine on the time to first cocaine use and abstinence rates in 60 treatment-seeking cocaine-dependent individuals receiving mindfulness-based relapse prevention (MBRP) therapy, using a 5 week combined laboratory-inpatient and outpatient double-blind, randomized, controlled trial.

Target Enrollment
55 participants
Study Type
Phase I/II interventional
Design
Randomized, quadruple Blind

Study Arms & Interventions

Ketamine

experimental

A single 40-minute intravenous infusion of ketamine (0.5 mg/kg) combined with a 5-week course of mindfulness-based relapse prevention (MBRP).

Interventions

  • Ketamine0.5 mg/kg
    via IVsingle dose1 doses total

    40-minute slow-drip infusion; combined with MBRP

Midazolam

active comparator

A single 40-minute intravenous infusion of midazolam (0.025 mg/kg) combined with a 5-week course of mindfulness-based relapse prevention (MBRP).

Interventions

  • Placebo0.025 mg/kg
    via IVsingle dose1 doses total

    40-minute slow-drip infusion; used as active control; combined with MBRP

Study Details

  • Status
    Terminated
  • Phase
    Phase IPhase II
  • Type
    interventional
  • Design
    Randomizedquadruple Blind
  • Target Enrollment55 participants
  • Timeline
    Start: 2012-02-01
    End: 2017-04-01
  • Compounds

Study Team

Sponsors & Collaborators

Related Publications